| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 18392 |
| 1 | EVOLOCUMAB | 17173 |
| 2 | ERENUMAB-AOOE | 10273 |
| 3 | ETANERCEPT | 6496 |
| 4 | PEGFILGRASTIM | 5007 |
| 5 | GUSELKUMAB | 3707 |
| 6 | SECUKINUMAB | 2738 |
| 7 | MEPOLIZUMAB | 1840 |
| 8 | GOLIMUMAB | 1787 |
| 9 | FREMANEZUMAB-VFRM | 1501 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGFILGRASTIM | 5007 | 0.4180 |
| 1 | ADALIMUMAB-AQVH | 34 | 0.3434 |
| 2 | ERENUMAB-AOOE | 10273 | 0.1849 |
| 3 | GOLIMUMAB | 1787 | 0.1419 |
| 4 | VALRUBICIN | 23 | 0.1292 |
| 5 | FREMANEZUMAB-VFRM | 1501 | 0.1268 |
| 6 | EVOLOCUMAB | 17173 | 0.1040 |
| 7 | ADALIMUMAB-ATTO | 164 | 0.1019 |
| 8 | GUSELKUMAB | 3707 | 0.0970 |
| 9 | INSULIN GLARGINE AND LIXISENATIDE | 340 | 0.0929 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 18392 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 7226 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2346 |
| 3 | Insulin Analog [EPC] | 2283 |
| 4 | Corticosteroid [EPC] | 1772 |
| 5 | Interleukin-12 Antagonist [EPC] | 1505 |
| 6 | Interleukin-23 Antagonist [EPC] | 1505 |
| 7 | RANK Ligand Inhibitor [EPC] | 1400 |
| 8 | Catecholamine [EPC] | 1091 |
| 9 | GLP-1 Receptor Agonist [EPC] | 1091 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Copper Absorption Inhibitor [EPC] | 1 | 0.5000 |
| 1 | Inhalation Diagnostic Agent [EPC] | 1 | 0.0769 |
| 2 | Semifluorinated Alkane [EPC] | 134 | 0.0576 |
| 3 | Interleukin-4 Receptor alpha Antagonist [EPC] | 18392 | 0.0355 |
| 4 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1058 | 0.0330 |
| 5 | Ectoparasiticide [EPC] | 115 | 0.0294 |
| 6 | Oxaborole Antifungal [EPC] | 2 | 0.0286 |
| 7 | Polymyxin-class Antibacterial [EPC] | 2 | 0.0274 |
| 8 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 46 | 0.0258 |
| 9 | Human Immunoglobulin [EPC] | 1 | 0.0196 |